RecruitingPhase 3NCT06739122
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Sponsor: Eli Lilly and Company
Jacksonville, FL · Miami, FL · Orlando, FL · +38 more sites
1 recruiting type 2 diabetes studies with a site in Tamarac, FL.
Sponsor: Eli Lilly and Company
Jacksonville, FL · Miami, FL · Orlando, FL · +38 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.